Immunovant Ownership | Who Owns Immunovant?

Overview ForecastFinancials Chart Transcripts

Immunovant Ownership Summary

Immunovant is owned by 55.30% institutional investors, 56.77% insiders. Fmr is the largest institutional shareholder, holding 8.62% of IMVT shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.87% of its assets in Immunovant shares.

IMVT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Immunovant	55.30%	56.77%	-12.07%
Sector	Healthcare Stocks	42.03%	10.80%	47.17%
Industry	Biotech Stocks	44.27%	10.76%	44.97%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	14.73M	8.62%	$237.44M
Deep track capital, lp	9.73M	5.69%	$156.83M
Vanguard group	6.83M	4.00%	$110.05M
Blackrock	4.92M	3.56%	$129.79M
Armistice capital	5.84M	3.42%	$94.08M
Blackrock funding, inc. /de	5.74M	3.36%	$92.50M
Baker bros. advisors lp	5.46M	3.19%	$87.98M
T. rowe price investment management	5.16M	3.02%	$83.25M
Point72 asset management	3.44M	2.01%	$55.49M
State street	2.89M	1.69%	$46.63M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Alpine global management	2.75M	7.65%	$44.41M
Superstring capital management lp	341.35K	5.42%	$5.50M
Stempoint capital lp	1.59M	5.13%	$25.62M
Deep track capital, lp	9.73M	4.38%	$156.83M
Adar1 capital management	2.24M	3.39%	$36.14M
Great point partners	500.00K	3.32%	$8.06M
Prosight management, lp	698.47K	2.63%	$11.26M
Exome asset management	158.62K	1.55%	$2.56M
Armistice capital	5.84M	1.40%	$94.08M
Boxer capital	825.00K	1.15%	$21.78M

Top Buyers

Holder	Shares	% Assets	Change
Adar1 capital management	2.24M	3.39%	1.71M
Norges bank	637.95K	0.00%	637.95K
Armistice capital	5.84M	1.40%	636.00K
Two seas capital lp	2.76M	0.71%	509.27K
Blackrock	4.92M	0.00%	439.33K

Top Sellers

Holder	Shares	% Assets	Change
Fmr	14.73M	0.01%	-3.87M
T. rowe price investment management	5.16M	0.05%	-1.71M
Paradigm biocapital advisors lp	-	-	-1.36M
Viking global investors lp	-	-	-1.11M
Franklin resources	-	-	-984.06K

New Positions

Holder	Shares	% Assets	Change	Value
Norges bank	637.95K	0.00%	637.95K	$15.80M
Superstring capital management lp	341.35K	5.42%	341.35K	$5.50M
Assenagon asset management	205.22K	0.00%	205.22K	$3.31M
Balyasny asset management	197.57K	0.00%	197.57K	$3.16M
Exome asset management	158.62K	1.55%	158.62K	$2.56M

Sold Out

Holder	Change
Reuter james wealth management	-1.00
Physician wealth advisors	-1.00
Twin peaks wealth advisors	-3.00
Capital performance advisors llp	-3.00
Nelson, van denburg & campbell wealth management group	-11.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	191	5.52%	94,495,463	-1.81%	55	1.74%	93	-6.06%	51	2.00%
Jun 30, 2025	178	-15.64%	96,201,301	3.59%	56	1.41%	96	-25.58%	50	19.05%
Mar 31, 2025	212	2.42%	94,119,777	17.45%	64	2.15%	130	23.81%	43	-30.65%
Dec 31, 2024	197	-3.90%	76,056,919	-3.29%	51	1.80%	100	5.26%	58	-9.38%
Sep 30, 2024	204	-4.23%	78,645,357	5.27%	53	2.05%	94	-14.55%	64	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	6.75M	3.87%	8.91K
Fidelity Growth Compy Commingled Pl O	4.45M	3.04%	196.00K
Fidelity Growth Company Fund	4.81M	2.76%	-28.82K
T. Rowe Price US Small-Cap Core Equity	2.55M	1.49%	140.80K
T. Rowe Price Small-Cap Stock	2.45M	1.41%	-92.78K
Vanguard US Total Market Shares ETF	2.12M	1.25%	2.26K
Vanguard Total Stock Mkt Idx Inv	2.13M	1.24%	-47.17K
Vanguard Small Cap Index	1.66M	0.97%	-11.12K
iShares Russell 2000 ETF	1.63M	0.94%	-
Fidelity Growth Company K6	1.47M	0.84%	3.41K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 22, 2025	Geffner Michael	Chief Medical Officer	Sell	$49.38K
Oct 22, 2025	Stout Jay S	Chief Technology Officer	Sell	$47.96K
Oct 08, 2025	Geffner Michael	Chief Medical Officer	Sell	$20.73K
Oct 08, 2025	Stout Jay S	Chief Technology Officer	Sell	$25.84K
Jul 23, 2025	Stout Jay S	Chief Technology Officer	Sell	$50.91K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	4
2025 Q3	-	4
2025 Q2	-	5
2025 Q1	1	17
2024 Q4	-	16

IMVT Ownership FAQ

Who Owns Immunovant?

Immunovant shareholders are primarily institutional investors at 55.30%, followed by 56.77% insiders and -12.07% retail investors. The average institutional ownership in Immunovant's industry, Biotech Stocks , is 44.27%, which Immunovant exceeds.

Who owns the most shares of Immunovant?

Immunovant’s largest shareholders are Fmr (14.73M shares, 8.62%), Deep track capital, lp (9.73M shares, 5.69%), and Vanguard group (6.83M shares, 4.00%). Together, they hold 18.31% of Immunovant’s total shares outstanding.

Does Blackrock own Immunovant?

Yes, BlackRock owns 3.56% of Immunovant, totaling 4.92M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 129.79M$. In the last quarter, BlackRock increased its holdings by 439.33K shares, a 9.81% change.

Who is Immunovant’s biggest shareholder by percentage of total assets invested?

Alpine global management is Immunovant’s biggest shareholder by percentage of total assets invested, with 7.65% of its assets in 2.75M Immunovant shares, valued at 44.41M$.

Who is the top mutual fund holder of Immunovant shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Immunovant shares, with 3.87% of its total shares outstanding invested in 6.75M Immunovant shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools